...
首页> 外文期刊>Vaccine >Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis
【24h】

Lipopolysaccharide from Burkholderia thailandensis E264 provides protection in a murine model of melioidosis

机译:泰国伯克霍尔德氏菌E264的脂多糖在类拟oid病小鼠模型中提供保护

获取原文
获取原文并翻译 | 示例
           

摘要

Burkholderia thailandensis is a less virulent close relative of Burkholderia pseudomallei, a CDC category B biothreat agent. We have previously shown that lipopolysaccharide (LPS) extracted from B. pseudomallei can provide protection against a lethal challenge of B. pseudomallei in a mouse model of melioidosis. Sugar analysis on LPS from B. thailandensis strain E264 confirmed that this polysaccharide has a similar structure to LPS from B. pseudomallei. Mice were immunised with LPS from B. thailandensis or B. pseudomallei and challenged with a lethal dose of B. pseudomallei strain K96243. Similar protection levels were observed when either LPS was used as the immunogen. This data suggests that B. thailandensis LPS has the potential to be used as part of a subunit based vaccine against pathogenic B. pseudomallei
机译:伯克霍尔德氏菌是CDC B类生物威胁因子假伯克霍尔德氏菌的低毒近亲。以前我们已经表明,从拟假芽孢杆菌提取的脂多糖(LPS)可以提供针对拟人病小鼠模型中的致命假拟芽孢杆菌攻击的保护作用。对来自泰国芽孢杆菌E264菌株的LPS的糖分析证实,该多糖具有与来自假苹果芽孢杆菌的LPS相似的结构。用来自泰国芽孢杆菌或假芽孢杆菌的LPS免疫小鼠,并用致死剂量的假芽孢杆菌K96243攻击。当将任一LPS用作免疫原时,观察到相似的保护水平。该数据表明,泰国枯草芽孢杆菌LPS有潜力用作针对病原性假苹果芽孢杆菌的亚基疫苗的一部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号